Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event. Blood 2014 May 01;123(18):2895-7
Date
05/03/2014Pubmed ID
24786458Pubmed Central ID
PMC4007615DOI
10.1182/blood-2014-03-561878Scopus ID
2-s2.0-84903139938 (requires institutional sign-in at Scopus site) 52 CitationsAuthor List
Gandhi MD, Evens AM, Fenske TS, Hamlin P, Coiffier B, Engert A, Moskowitz AJ, Ghosh N, Petrich AM, Lomasney J, Chadburn A, Wood GS, Salva K, Nardone B, Trifilio SM, Raisch DW, West DP, Gordon LI, Winter JNAuthor
Timothy Fenske MD Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdultAged
Antineoplastic Agents
Autopsy
Fatal Outcome
Female
Hodgkin Disease
Humans
Immunoconjugates
Lymphoma, Large-Cell, Anaplastic
Male
Middle Aged
Pancreatitis
Treatment Outcome
Young Adult
